Robert P. Bresnahan, Jr. sold ResMed Inc (NYSE: RMD)
Robert P. Bresnahan, Jr. (R-PA), a U.S. Representative, has disclosed 1 trade in ResMed Inc (RMD) since 2025, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Robert P. Bresnahan, Jr. sold $1,001 - $15,000 of ResMed Inc (NYSE: RMD) on January 13, 2025. Since that trade, RMD is down -8.13% against the S&P 500 up +29.42%, an outperformance of -37.56%.
Data updated
Robert P. Bresnahan, Jr.'s RMD trades vs the price
RMD is down -8.13% since Robert P. Bresnahan, Jr. sold on January 13, 2025, versus +29.42% for the S&P 500.
Performance since this trade
All Robert P. Bresnahan, Jr. RMD trades
Robert P. Bresnahan, Jr. & RMD trading FAQ
Is it legal for Robert P. Bresnahan, Jr. to trade ResMed Inc (RMD) stock?
Yes. Members of Congress are allowed to trade individual stocks, including ResMed Inc (RMD), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Robert P. Bresnahan, Jr. sell RMD?
Robert P. Bresnahan, Jr. disclosed a sale of $1,001 - $15,000 of ResMed Inc (RMD) on January 13, 2025, according to public STOCK Act filings.
How has RMD performed since Robert P. Bresnahan, Jr.'s trade?
Since Robert P. Bresnahan, Jr. sold RMD on January 13, 2025, the stock is down -8.13%, versus +29.42% for the S&P 500 over the same period, an outperformance of -37.56%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional RMD trades?
Quantellect tracks every disclosed congressional trade in ResMed Inc (RMD) on the ResMed Inc congressional trading page, which aggregates filings across all members of Congress.
Robert P. Bresnahan, Jr.'s RMD tradesAll congressional filings for ResMed IncRobert P. Bresnahan, Jr.'s full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.